[A multicenter study of rituximab-based regimen as first-line treatment in patients with follicular lymphoma]

Zhonghua Xue Ye Xue Za Zhi. 2014 May;35(5):456-8. doi: 10.3760/cma.j.issn.0253-2727.2014.05.018.

[Article in Chinese]

Affiliation

¹ Jiangsu Cancer Hospital. Nanjing 210000, China.

PMID: 24857221
DOI: 10.3760/cma.j.issn.0253-2727.2014.05.018

No abstract available

Publication types

Multicenter Study

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Follicular / drug therapy*
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab